sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib
Year: 2014
Type: article
Source: Journal of Controlled Release
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
Award: G1345569834
OpenAlex ID: W2088190878
